New Anti-Choking Device Offers Life-Saving Solution for Children and Adults

  • Choking is a leading cause of injury and death, particularly among children. Each year, thousands of individuals experience choking incidents, which can lead to severe outcomes if not promptly addressed. To combat this pressing issue, Sonmol is excited to introduce an innovative anti-choking device designed to save lives and provide peace of mind.
  • Choking Rescue Device applies the principle of negative pressure suction to create an automatic vacuum environment that instantaneously extracts foreign matter from the throat and upper airway. Various anti-choking devices are available on the market, and they all function similarly by providing suction to clear airway obstructions. However, the operator must apply pressure to these devices by pressing and pulling the handle. If the operator is not in good physical condition, they may not be able to provide enough pressure to suck out the foreign matter.
  • The advantage of this Choking Rescue Device is that all the operator needs to do is place it correctly and press the trigger button—it provides safe, steady, and robust pressure to help with choking rescues. If the Heimlich maneuver fails and care centers are far away, it can be considered an alternative way to deal with choking emergencies before an ambulance comes.

Our device, featured on Sonmol’s official website, offers a simple yet highly effective solution for choking emergencies. With a focus on ease of use and rapid response, anyone can operate it, making it an essential addition to homes, schools, restaurants, and public spaces.

Anti-Chocking Device For Kids

Key Features:

  • User-Friendly Design: The device is intuitive, allowing untrained individuals to administer aid quickly and effectively.
  • Compact and Portable: Its lightweight construction ensures it can be carried and stored conveniently, ready for use immediately.
  • Proven Efficacy: Clinical trials and real-world applications have demonstrated the device’s high success in clearing obstructed airways. The double one-way valve prevents air from pushing the obstruction deeper.
  • FDA Registered: USFDA, Thai FDA, CE approved
  • Three masks packed: One for toddlers, one for children, and one for adults.
  • Easy to Use: Place and Press. User-friendly for individuals with limited hand strength.

Why It Matters:

Choking can occur unexpectedly, and the ability to respond immediately is critical. Traditional methods like the Heimlich maneuver are effective but require proper execution and can sometimes fail. Our anti-choking device addresses these challenges, providing a reliable alternative that enhances safety in various environments.

Frequently asked questions:

  1. How to use Choking Rescue Device in an emergency?

In a choking emergency, you should first call for medical help. While waiting for help to arrive, you can use the choking rescue device. Always follow the instructions provided with your device kit.

  1. Can Choking Rescue Device be self-administered?

Yes. If you are unable to breathe or cough effectively, and you’re alone, it may be necessary to use a choking rescue device on yourself. Place the face mask over your mouth and nose, ensuring a tight seal to allow for effective suction. Push the trigger to release suction power.

  1. Is shipping worldwide? And how long does shipping take?

Yes! For the United States it typically takes 2-5 days (and a little longer for Canada).

  1. For the Rest of World it can take 10-15 days depending on location.

You will get our tracking number.

  1. Does it come with a warranty?

Sure we do. We offer a 1-year warranty on our device.

  1. Is contract manufacturing and OEM service available?

Yes! We will help design and adjust the device’s color and send the original package design to contract buyers as a reference for their own package.

  1. Is masks and tubes available if used out?

Yes! We will provide masks and tubes in different shapes on our website.

Learn More:

Visit Sonmol’s official website for detailed information about our product, including instructional videos, testimonials, and purchasing options. Together, we can reduce the risk of choking incidents and save lives.

 

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”